Aldeyra Therapeutics Ownership | Who Owns Aldeyra Therapeutics?


OverviewForecastFinancialsChart

Aldeyra Therapeutics Ownership Summary


Aldeyra Therapeutics is owned by 7.52% institutional investors, 3.09% insiders, and 89.39% retail investors. Knoll capital management is the largest institutional shareholder, holding 9.12% of ALDX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.97% of its assets in Aldeyra Therapeutics shares.

ALDX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAldeyra Therapeutics7.52%3.09%89.39%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Knoll capital management5.48M9.12%$28.58M
Perceptive advisors5.22M8.70%$27.26M
Blackrock funding, inc. /de3.85M6.40%$19.94M
Vanguard group3.70M6.15%$19.16M
Blackrock3.62M6.10%$11.99M
Ardsley advisory partners lp1.90M3.16%$9.92M
Kingdon capital management1.33M2.22%$6.95M
Geode capital management1.17M1.95%$6.06M
Kennedy capital management1.11M1.85%$5.81M
State street1.10M1.83%$5.69B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Knoll capital management5.48M15.32%$28.58M
Ardsley advisory partners lp1.90M1.23%$9.92M
Kingdon capital management1.33M0.86%$6.95M
Perceptive advisors5.22M0.79%$27.26M
1492 capital management223.32K0.44%$1.16M
683 capital management820.00K0.22%$4.28M
Palo alto investors lp225.47K0.22%$1.18M
Alphacentric advisors34.91K0.18%$180.84K
Kennedy capital management1.11M0.13%$5.81M
Woodstock266.76K0.12%$1.38M

Top Buyers

HolderShares% AssetsChange
Perceptive advisors5.22M0.79%1.17M
Kennedy capital management1.11M0.13%425.25K
Blackrock3.62M0.00%311.16K
Bnp paribas arbitrage, snc263.41K0.00%252.80K
1492 capital management223.32K0.44%223.32K

Top Sellers

HolderShares% AssetsChange
Federated hermes---551.09K
Morgan stanley657.03K0.00%-426.29K
Johnson & johnson---299.67K
683 capital management820.00K0.22%-260.00K
Adar1 capital management---249.92K

New Positions

HolderShares% AssetsChangeValue
1492 capital management223.32K0.44%223.32K$1.16M
State of wisconsin investment board60.89K0.00%60.89K$317.87K
Quantinno capital management lp51.32K0.00%51.32K$267.91K
Graham capital management45.92K0.00%45.92K$239.71K
Alphacentric advisors34.91K0.18%34.91K$180.84K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-9.00
Capital performance advisors llp-17.00
Parallel advisors-30.00
Innealta capital-46.00
Wolff wiese magana-113.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202530-78.26%4,523,979-88.49%70.18%10-88.10%13-48.00%
Sep 30, 202546-61.67%5,222,346-83.31%80.32%22-63.93%10-70.59%
Jun 30, 2025128-4.48%34,265,682-9.56%571.43%6626.92%35-25.53%
Mar 31, 202512-90.32%15,581,741-57.99%260.67%5-91.94%3-88.00%
Dec 31, 20241235.13%31,618,255-13.84%531.40%623.33%254.17%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.78M2.97%-
Vanguard US Total Market Shares ETF1.76M2.95%-
iShares Russell 2000 ETF1.34M2.23%1.34M
Kennedy Small Cap Select692.53K1.15%57.43K
Fidelity Small Cap Index555.10K0.92%-660.00
Vanguard Institutional Extnd Mkt Idx Tr508.30K0.84%-
AZ Fd 1 - AZ Eq - Amer Opps A-EUR Acc421.85K0.70%-36.02K
iShares Russell 2000 Value ETF412.16K0.69%-
Invesco Dorsey Wright SmallCap Momt ETF406.98K0.68%-
iShares Russell 2000 Growth ETF367.17K0.61%-36.86K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 13, 2025Alfieri Michael Principal Financial OfficerBuy$13.25K
Aug 11, 2025Machatha Stephen Chief Development OfficerSell$113.71K
Apr 03, 2025PERCEPTIVE ADVISORS LLC-Sell$4.83M
May 03, 2021Miller-Rich Nancy-Buy$5.29K
Apr 12, 2023Miller-Rich Nancy-Buy$5.16K

Insider Transactions Trends


DateBuySell
2025 Q311
2025 Q2-1
2025 Q1--
2024 Q3-2
2024 Q25-

ALDX Ownership FAQ


Who Owns Aldeyra Therapeutics?

Aldeyra Therapeutics shareholders are primarily institutional investors at 7.52%, followed by 3.09% insiders and 89.39% retail investors. The average institutional ownership in Aldeyra Therapeutics's industry, Biotech Stocks , is 381.47%, which Aldeyra Therapeutics falls below.

Who owns the most shares of Aldeyra Therapeutics?

Aldeyra Therapeutics’s largest shareholders are Knoll capital management (5.48M shares, 9.12%), Perceptive advisors (5.22M shares, 8.70%), and Blackrock funding, inc. /de (3.85M shares, 6.40%). Together, they hold 24.22% of Aldeyra Therapeutics’s total shares outstanding.

Does Blackrock own Aldeyra Therapeutics?

Yes, BlackRock owns 6.10% of Aldeyra Therapeutics, totaling 3.62M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.99M$. In the last quarter, BlackRock increased its holdings by 311.16K shares, a 9.40% change.

Who is Aldeyra Therapeutics’s biggest shareholder by percentage of total assets invested?

Knoll capital management is Aldeyra Therapeutics’s biggest shareholder by percentage of total assets invested, with 15.32% of its assets in 5.48M Aldeyra Therapeutics shares, valued at 28.58M$.

Who is the top mutual fund holder of Aldeyra Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aldeyra Therapeutics shares, with 2.97% of its total shares outstanding invested in 1.78M Aldeyra Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools